Leading the way to safer medication
 Crosscheck  Recommender

Klaricid 250mg Tablets (2011)

Active ingredients: Clarithromycin

Product Name and Form

Klaricid or Clarithromycin 250 mg Tablets.

Pharmaceutical form

A yellow, ovaloid film-coated tablet containing 250 mg of clarithromycin.

Qualitative and Quantitative Composition

250 mg/tablet.

Active: Clarithromycin.

Chemical substance
Description
Clarithromycin

Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria.

List of excipients

Croscarmellose sodium
Starch pregelatinised
Cellulose microcrystalline
Silica gel
Povidone
Stearic acid
Magnesium stearate
Talc
Hypromellose
Hydroxypropylcellulose
Propylene glycol
Sorbitan monooleate
Titanium dioxide
Sorbic acid
Vanillin
Quinoline yellow E104

Pack sizes and Marketing

2/14/56 tablets in a blister original pack. The blisters are packaged in a carton with a pack insert.

Marketing authorization holder
Authorization dates

Abbott Laboratories Limited
Abbott House
Vanwall Business Park
Vanwall Road
Maidenhead
Berkshire
SL6 4XE
UK

09/04/91

Marketing authorization number:

PL 0037/0211